PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
 
Infect Immun. 1975 July; 12(1): 137–142.
PMCID: PMC415257

Biochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensis.

Abstract

Ribonucleic acid (RNA)-rich extracts derived from the attenuated strain of Francisella tularensis (strain LVS) protected Swiss mice against lethal challenge with F. tularensis strain 425 but not against strain SCHU S4. No killed preparation, including an RNA-rich extract from SCHU S4 itself, offered protection against strain SCHU S4 in contrast to the high level of protection offered against this strain by vaccination with live strain LVS. The protective activity observed against strain 425 was sensitive to ribonuclease but not to Pronase. Protective activity is not a general property of bacterial RNA, since RNA-rich extracts from Staphylococcus aureus offered no protection against tularemia, although disc gel electrophoresis showed similar kinds and amounts of RNA in preparations form F. tularensis and S. aureus. Furthermore, inability to localize activity to a specific region in sucrose gradients suggests a structural rather than an informational role for the RNA in such extracts. RNA-rich extracts from F. tularensis but not from S. aureus were efficient inducers of F. tularensis opsonins in mouse serum, suggesting one mechanism by which such extracts confer protection.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (837K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • ALEXANDER MM, WRIGHT GG, BALDWIN AC. Observations on the agglutination of polysaccharide-treated erythrocytes by tularemia antisera. J Exp Med. 1950 Jun 1;91(6):561–566. [PMC free article] [PubMed]
  • Araujo FG, Remington JS. Protection against Toxoplasma gondii in mice immunized with Toxoplasma cell fractions, RNA and synthetic polyribonucleotides. Immunology. 1974 Oct;27(4):711–721. [PubMed]
  • Archer SJ, Wust CJ. Preliminary characterization of "immunogenic" ribonucleic acid derived from rat peritoneal exudate cells. Infect Immun. 1973 Aug;8(2):215–221. [PMC free article] [PubMed]
  • Bell C, Dray S. Conversion of non-immune rabbit spleen cells by ribonucleic acid of lymphoid cells from an immunized rabbit to produce IgM and IgG antibody of foreign heavy-chain allotype. J Immunol. 1971 Jul;107(1):83–95. [PubMed]
  • Bourque DP, Naylor AW. A simple electrophoretic procedure for separation of RNA on mixed agarose-acrylamide gel columns. J Chromatogr. 1971 Mar 24;56(1):79–86. [PubMed]
  • DeChatelet LR, Mullikin D, Shirley PS, McCall CE. Phagocytosis of live versus heat-killed bacteria by human polymorphonuclear leukocytes. Infect Immun. 1974 Jul;10(1):25–29. [PMC free article] [PubMed]
  • Duke LJ, Miller C, Harshman S. Induction of antibody synthesis by purified immunogenic RNA in vitro. Nat New Biol. 1972 Feb 9;235(58):180–182. [PubMed]
  • EIGELSBACH HT, DOWNS CM. Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. J Immunol. 1961 Oct;87:415–425. [PubMed]
  • Fishman M, Adler FL. The formation of immunogenic RNA-antigen complexes in a cell-free system. Cell Immunol. 1973 Aug;8(2):221–234. [PubMed]
  • Guentzel MN, Berry LJ. Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens. Infect Immun. 1974 Jul;10(1):167–172. [PMC free article] [PubMed]
  • Jensen R, Gregory B, Naylor J, Actor P. Isolation of protective somatic antigen from Vibrio cholerae (Ogawa) ribosomal preparations. Infect Immun. 1972 Aug;6(2):156–161. [PMC free article] [PubMed]
  • LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed]
  • Margolis JM, Bigley NJ. Cytophilic macroglobulin reactive with bacterial protein in mice immunized with ribonucleic acid-protein fractions of virulent Salmonella typhimurium. Infect Immun. 1972 Sep;6(3):390–397. [PMC free article] [PubMed]
  • Meiss HK, Fishman M. Formation of antibody in rabbit spleen cell cultures stimulated with immunogenic RNA. J Immunol. 1972 May;108(5):1172–1178. [PubMed]
  • Metzger JF, Johnson AD, Collins WS, 2nd, McGann V. Staphylococcus aureus enterotoxin B release (excretion) under controlled conditions of fermentation. Appl Microbiol. 1973 May;25(5):770–773. [PMC free article] [PubMed]
  • Neiburger RG, Youmans GP, Youmans AS. Relationship between tuberculin hypersensitivity and cellular immunity to infection in mice vaccinated with viable attenuated Mycobacterial cells or with Mycobacterial ribonucleic acid preparations. Infect Immun. 1973 Jul;8(1):42–47. [PMC free article] [PubMed]
  • Proctor RA, White JD, Ayala E, Canonico PG. Phagocytosis of Francisella tularensis by Rhesus monkey peripheral leukocytes. Infect Immun. 1975 Jan;11(1):146–151. [PMC free article] [PubMed]
  • SASLAW S, EIGELSBACH HT, PRIOR JA, WILSON HE, CARHART S. Tularemia vaccine study. II. Respiratory challenge. Arch Intern Med. 1961 May;107:702–714. [PubMed]
  • Smith RA, Bigley NJ. Detection of delayed hypersensitivity in mice injected with ribonucleic acid-protein fractions of Salmonella typhimurium. Infect Immun. 1972 Sep;6(3):384–389. [PMC free article] [PubMed]
  • Smith RA, Bigley NJ. Ribonucleic acid-protein fractions of virulent Salmonella typhimurium as protective immunogens. Infect Immun. 1972 Sep;6(3):377–383. [PMC free article] [PubMed]
  • Thomas DW, Weiss E. Response of mice to injection of ribosomal fraction from group B Neisseria meningitidis. Infect Immun. 1972 Sep;6(3):355–363. [PMC free article] [PubMed]
  • Thompson HC, Snyder IS. Protection against pneumococcal infection by a ribosomal preparation. Infect Immun. 1971 Jan;3(1):16–23. [PMC free article] [PubMed]
  • Veltman LL, Kern DH, Pilch YH. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" RNA. Cell Immunol. 1974 Sep;13(3):367–377. [PubMed]
  • Venneman MR, Bigley NJ, Berry LJ. Immunogenicity of Ribonucleic Acid Preparations Obtained from Salmonella typhimurium. Infect Immun. 1970 Jun;1(6):574–582. [PMC free article] [PubMed]
  • Vyas GN, Ibrahim AB, Rao KR, Likhite V. In vitro transfer of cell-mediated immunity to hepatitis B antigen with RNA. Nature. 1974 Feb 8;247(5440):377–378. [PubMed]
  • Winston SH, Berry LJ. Antibacterial immunity induced by ribosomal vaccines. J Reticuloendothel Soc. 1970 Jul;8(1):13–24. [PubMed]
  • Winston S, Berry LJ. Immunity induced by ribosomal extracts from Staphylococcus aureus. J Reticuloendothel Soc. 1970 Jul;8(1):66–73. [PubMed]
  • Youmans AS, Youmans GP. The effect of metabolic inhibitors and hydroxylamine on the immune response in mice to mycobacterial ribonucleic acid vaccines. J Immunol. 1974 Jan;112(1):271–284. [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)